You have 9 free searches left this month | for more free features.

Grade IV Glioma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)

Recruiting
  • Glioblastoma Multiforme
  • Perillyl alcohol
  • Los Angeles, California
  • +1 more
Sep 23, 2022

Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)

Not yet recruiting
  • Grade III or Grade IV Glioma
  • PET imaging with 18F fluciclovine
  • (no location specified)
Jul 27, 2022

Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)

Recruiting
  • Glioblastoma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 10, 2022

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)

    Not yet recruiting
    • High Grade Glioma
    • Glioblastoma
    • Standard Surgical Treatment
    • Intraoperative Electrocorticography
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Sep 30, 2022

    Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

    Not yet recruiting
    • Malignant Glioma
    • Glioblastoma
    • hEGFRvIII-CD3 (BRiTE)
    • Activated Cell Therapy
    • Durham, North Carolina
      Duke University Medical Center
    Jun 24, 2022

    Supramaximal Resection Versus Maximal Resection for High-Grade

    Recruiting
    • Glioblastoma
    • +11 more
    • Supramaximal resection
    • Maximal safe resection
    • San Francisco, California
    • +7 more
    Nov 1, 2023

    Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

    Suspended
    • Glioblastoma
    • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
    • +4 more
    • Durham, North Carolina
      Duke University Medical Center
    Aug 16, 2022

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

    Completed
    • GBM
    • +3 more
    • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
    • Durham, North Carolina
      Duke University Medical Center
    Jun 28, 2022

    Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

    Active, not recruiting
    • Glioma of Brain
    • Bern, Switzerland
    • +2 more
    Apr 7, 2022

    Malignant Glioma Trial in United States (PVSRIPO)

    Active, not recruiting
    • Malignant Glioma
    • PVSRIPO
    • San Francisco, California
    • +5 more
    Jun 28, 2022

    High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)

    Completed
    • High Grade Glioma
    • endurance training
    • +2 more
    • Basel, Switzerland
    • +1 more
    May 17, 2022

    Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

    Recruiting
    • Astrocytoma, Grade IV
    • +7 more
      • Valencia, Spain
        Biomedical Data Science Lab. Universitat Politècnica de València
      May 11, 2022

      Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)

      Recruiting
      • Glioma
      • Glioblastoma
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      Jan 31, 2022

      Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

      Active, not recruiting
      • Glioblastoma
      • +3 more
      • Stereotactic Radiosurgery
      • Lake Success, New York
        Northwell Health Brain Tumor Center
      Feb 3, 2022

      Intractable Epilepsy, Malignant Glioma, Seizure Disorder Trial in Jacksonville (Anticonvulsant Agent, Perampanel,

      Recruiting
      • Intractable Epilepsy
      • +2 more
      • Anticonvulsant Agent
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Nov 22, 2021

      Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

      Recruiting
      • Malignant Glioma
      • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
      • +2 more
      • Durham, North Carolina
        Duke University Medical Center
      Mar 22, 2022

      Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

      Recruiting
      • Glioblastoma
      • +2 more
      • Intensity-Modulated Radiation Therapy
      • Quality-of-Life
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Jun 3, 2021

      Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

      Recruiting
      • Grade II Glioma
      • +7 more
      • Microdevice
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 22, 2021

      Prospective Validation of Imaging Biomarkers Calculated at

      Recruiting
      • Astrocytoma, Grade IV
        • Valencia, Spain
          Universitat Politècnica de València
        Feb 7, 2022

        Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)

        Recruiting
        • Glioblastoma
        • High-grade Glioma
        • Groningen, Netherlands
          UMCG
        Jun 26, 2023

        Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

        Recruiting
        • Recurrent World Health Organization (WHO) Grade II Glioma
        • +3 more
        • Hyperpolarized Carbon C 13 Pyruvate
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Dec 21, 2022

        Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

        Recruiting
        • Low-Grade Glioma
        • +2 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Oct 24, 2022